BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 8839828)

  • 1. The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype.
    Melo JV
    Blood; 1996 Oct; 88(7):2375-84. PubMed ID: 8839828
    [No Abstract]   [Full Text] [Related]  

  • 2. Neutrophilic-chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR/ABL with C3/A2 junction).
    Pane F; Frigeri F; Sindona M; Luciano L; Ferrara F; Cimino R; Meloni G; Saglio G; Salvatore F; Rotoli B
    Blood; 1996 Oct; 88(7):2410-4. PubMed ID: 8839830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular biology of chronic myeloid leukaemia.
    Melo JV
    Leukemia; 1996 May; 10(5):751-6. PubMed ID: 8656667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular insights into the Philadelphia translocation.
    Heisterkamp N; Groffen J
    Hematol Pathol; 1991; 5(1):1-10. PubMed ID: 2050600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B2 exon of the BCR gene is also duplicated in some patients with CML.
    Almeida TA; Cigudosa JC; Otero A; Garcia-Miranda JL
    Leukemia; 1999 Apr; 13(4):645. PubMed ID: 10214875
    [No Abstract]   [Full Text] [Related]  

  • 6. BCR-ABL transcript with an e19a2 (c3a2) junction in classical chronic myeloid leukemia.
    Wilson G; Frost L; Goodeve A; Vandenberghe E; Peake I; Reilly J
    Blood; 1997 Apr; 89(8):3064. PubMed ID: 9108430
    [No Abstract]   [Full Text] [Related]  

  • 7. BCR/ABL rearrangement and leukemia phenotype.
    Saglio G; Pane F; Martinelli G; Guerrasio A
    Leukemia; 1999 Apr; 13 Suppl 1():S96. PubMed ID: 10232378
    [No Abstract]   [Full Text] [Related]  

  • 8. Application of fluorescence in situ hybridization in defining a complex t(9;21;22) Ph formation.
    Mancini M; Nanni M; Cedrone M; De Cuia MR; Rondinelli MB; Malagnino F; Alimena G
    Haematologica; 1994; 79(6):536-9. PubMed ID: 7896212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cytogenetics: Rosetta stone for understanding cancer--twenty-ninth G. H. A. Clowes memorial award lecture.
    Rowley JD
    Cancer Res; 1990 Jul; 50(13):3816-25. PubMed ID: 2191766
    [No Abstract]   [Full Text] [Related]  

  • 10. A novel e8a2 BCR-ABL1 intronic fusion through insertion of a chromosome 22 BCR gene fragment into chromosome 9 in an atypical Philadelphia (Ph) chromosome chronic myeloid leukemia patient.
    Chen L; Wu Y; You Y; Xiao M; Yao Y; Li W
    Leuk Lymphoma; 2016 Dec; 57(12):2930-2933. PubMed ID: 27118564
    [No Abstract]   [Full Text] [Related]  

  • 11. Malignant transformation by abl and BCR/ABL.
    Van Etten RA
    Cancer Treat Res; 1992; 63():167-92. PubMed ID: 1363357
    [No Abstract]   [Full Text] [Related]  

  • 12. Double fusion signal BCR/ABL, detected by FISH on chromosomes 9 and 22 in a child with ALL.
    Jarosová M; Mihál V; Holzerová M; Jedlicková K; Pospisilová ; Pikalová Z; Indrák K
    Leukemia; 2000 Jul; 14(7):1319-22. PubMed ID: 10914561
    [No Abstract]   [Full Text] [Related]  

  • 13. Leukemia cell lines: in vitro models for the study of Philadelphia chromosome-positive leukemia.
    Drexler HG; MacLeod RA; Uphoff CC
    Leuk Res; 1999 Mar; 23(3):207-15. PubMed ID: 10071072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic myeloid leukemia with a rare variant BCR-ABL translocation: t(9;22;21)(q34;q11.2;q11.2).
    Takeuchi M; Katayama Y; Okamura A; Yamamoto K; Shimoyama M; Matsui T
    Cancer Genet Cytogenet; 2007 Nov; 179(1):85-7. PubMed ID: 17981222
    [No Abstract]   [Full Text] [Related]  

  • 15. Differences between blastic chronic myeloid leukemia and Ph-positive acute leukemia.
    Berger R
    Leuk Lymphoma; 1993; 11 Suppl 1():235-7. PubMed ID: 8251902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two patients with novel BCR/ABL fusion transcripts (e8/a2 and e13/a2) resulting from translocation breakpoints within BCR exons.
    How GF; Lim LC; Kulkarni S; Tan LT; Tan P; Cross NC
    Br J Haematol; 1999 May; 105(2):434-6. PubMed ID: 10233416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the ABL-BCR fusion gene in Philadelphia-positive acute lymphoblastic leukemia.
    Melo JV; Gordon DE; Tuszynski A; Dhut S; Young BD; Goldman JM
    Blood; 1993 May; 81(10):2488-91. PubMed ID: 8490164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New approach in the diagnosis and monitoring of treatment in chronic myelogenous leukemia].
    Matolcsy A
    Orv Hetil; 2004 Dec; 145(52):2603-9. PubMed ID: 15724695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The Philadelphia chromosome: from the gene to therapeutic methods].
    Pérez-Losada J; González-Sarmiento R; Sánchez-García I
    Sangre (Barc); 1998 Apr; 43(2):127-35. PubMed ID: 9656774
    [No Abstract]   [Full Text] [Related]  

  • 20. Variant intra philadelphia translocation with rearrangement of BCR-ABL and ABL-BCR within the same chromosome in a patient with cALL.
    Edelhäuser M; Raber W; Mitterbauer G; Mannhalter C; Lechner K; Fonatsch C
    Cancer Genet Cytogenet; 2000 Oct; 122(2):83-6. PubMed ID: 11106816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.